On September 1, Americans for Safe Access officially launched Cannabis Safety Month with a virtual national forum titled "Cannabis Safety Month Opening National Forum: Framing the Conversation." As reported by mg Magazine, the event brought together advocates, healthcare professionals, researchers, and industry leaders to discuss patient safety, healthcare integration, and regulatory enforcement.

The national initiative is anchored by a clear theme: "Recognizing Community Concerns. Spotlighting Solutions. Building What Comes Next." The forum aimed to bridge gaps between patient needs, public safety, and federal cannabis policy reform.

Steph Sherer, founder and executive director of Americans for Safe Access, emphasized that safety and access must work together. She noted that while recognition of cannabis as medicine is growing, addressing safety concerns directly is essential to protect patients and build public support for comprehensive national medical cannabis legislation.

Scientific Evidence and Research Findings

The opening forum highlighted the critical role of scientific research and evidence-based policy in shaping the future of medical marijuana. Panelists emphasized that grounding public health policy in solid research helps eliminate fear and misinformation across the industry.

Julie K. Johnson, PhD, a cannabis policy researcher and applied policy leader, joined the panel to explore how evidence-based frameworks can inform effective regulations. Researchers emphasized that without clear scientific guidelines, regulatory bodies struggle to enforce standards that protect consumers.

Additionally, Sasha Kalcheff-Korn, executive director of Realm of Caring, contributed perspectives on tracking observational data and patient outcomes. The discussion underscored how clinical research and patient-reported data can refine understanding of proper administration, including CBD delivery dosage and THC delivery methods.

Our take: Establishing robust scientific research is not just an academic exercise—it is the foundation for safe patient care. When regulators rely on clinical evidence rather than speculation, medical cannabis programs become safer and more reliable for everyone.

Medical Applications and Patient Benefits

Medical marijuana offers vital support for patients navigating complex health conditions, but access barriers remain a significant challenge. The forum addressed how medical access deserts leave vulnerable populations without safe, regulated therapeutics.

For homebound patients or those living far from licensed dispensaries, patient delivery services and medical marijuana delivery play an essential role. Eliminating access deserts ensures that patients can reliably receive tested products without turning to illicit sources.

Shanetha Marable-Lewis, MS, executive director of Veterans Initiative 22, addressed the specific information gaps facing military veterans. Veterans often lack direct guidance from healthcare providers regarding therapeutic cannabis, making clear educational resources essential for safe use.

The forum reinforced that integrating cannabis into traditional healthcare settings requires honest conversations about efficacy and dosing. When healthcare providers are equipped with verified information, patients experience better therapeutic outcomes and safer administration routines.

Safety Considerations and Side Effects

Ensuring patient safety requires strong regulatory enforcement alongside public education. The forum panel examined how inadequately enforced regulations create public health risks and diminish community trust.

Kimberly Cargile, MS, owner and CEO of A Therapeutic Alternative, shared insights on operational safety and dispensary standards. She highlighted the responsibility of legal operators to address the concerns of parents and local community members regarding product safety and packaging.

Speakers also discussed the ongoing public health consequences of prohibition, which leaves consumers exposed to untested products. Unregulated products lack standard testing for potency, contaminants, and clear instructions on THC delivery methods or CBD delivery dosage.

Addressing community concerns directly allows the medical cannabis industry to build lasting public confidence. By enforcing strict safety guidelines, regulatory agencies can better protect patients from adverse effects and unreliable products.

What this means for DC, Maryland and Virginia

For medical cannabis patients and community stakeholders across Washington DC, Maryland, and Virginia, the launch of Cannabis Safety Month highlights key local priorities. The DMV region features diverse regulatory frameworks that directly impact patient access and product safety.

In Maryland and Virginia, where state-regulated medical markets operate alongside adult-use frameworks, regulatory enforcement remains vital for keeping untested products off store shelves. Meanwhile, patients across the DMV benefit significantly when cannabis home delivery benefits are expanded to resolve local access deserts.

District of Columbia patients and advocates continue to navigate unique federal and local policy challenges. Aligning DMV standards with the national solutions discussed by Americans for Safe Access helps strengthen local patient protections and veteran outreach initiatives.

As DMV jurisdictions continue refining their rules, prioritizing evidence-based safety and clear consumer education ensures that local dispensaries maintain the highest standards of care.

What is the primary goal of Cannabis Safety Month?

Cannabis Safety Month, organized by Americans for Safe Access, aims to bring stakeholders together to examine evidence, address safety concerns, protect patients, and advocate for comprehensive national medical cannabis legislation.

Why are patient delivery services important for cannabis safety?

Patient delivery services help eliminate access deserts by providing homebound or rural patients with direct access to lab-tested, regulated medical marijuana products, reducing reliance on unsafe or unverified sources.

How do regulatory enforcement gaps impact consumer safety?

When regulations are not adequately enforced, untested products with inaccurate potency labels or unknown contaminants can enter the marketplace, posing potential public health risks to consumers and patients.

Who participated in the Cannabis Safety Month opening forum?

The forum featured leaders including Steph Sherer (Americans for Safe Access), Sasha Kalcheff-Korn (Realm of Caring), Shanetha Marable-Lewis (Veterans Initiative 22), policy researcher Julie K. Johnson, PhD, and dispensary CEO Kimberly Cargile, MS.

Takeaways and Resources for Further Medical Consultation

Cannabis Safety Month serves as a reminder that safety and patient access are complementary goals. Addressing community concerns honestly is essential for building a transparent, patient-first medical cannabis framework.

Patients seeking guidance on medical marijuana delivery, product dosing, or specific administration methods should consult with licensed healthcare professionals and verified patient advocacy organizations like Americans for Safe Access and Realm of Caring.

Source: mg Magazine – Premier B2B Cannabis Magazine | Trusted Cannabis News

Written by Cannabis Science AI

Bud Lords AI Cannabis News Writer

Research scientist specializing in cannabis studies, terpene research, cannabinoid science, cultivation technology, and peer-reviewed cannabis research. Translates complex scientific findings into practical insights.

Expertise: science · research · terpenes · cannabinoids · cultivation · technology

View more from Cannabis Science AI

This AI-assisted article was created using the named Bud Lords newsroom personality and reviewed under Bud Lords editorial standards.